Luisa Salter-Cid, Ph.D., M.Sc., is the Chief Scientific Officer at Pioneering Medicines, a division of life sciences company Flagship Pioneering. Before this, she served at Chief Scientific Officer at Gossamer Bio where she established a large research team and clinical portfolio that was integral in the company’s IPO in 2019. Prior to Gossamer Bio, Dr. Salter-Cid served as Vice President at Bristol-Myers Squibb, heading the immunology, small molecule immuno-oncology and genomics teams. Presently, Dr. Salter-Cid serves on the Board of Directors for Jounce Therapeutics and is a member of the Scientific Advisory Boards of both Prometheus Biosciences and Enterome. She has authored over 80 publications and patents, and received her doctorate in immunology from the University of Miami.